Overview

A Study Of Three PF-05190457 Formulations In Healthy Volunteers

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the plasma drug concentrations of three formulations of PF-05190457 after administration of single doses to healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer